Fig. 3From: In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina FasoMean geometric IC50 values at day 0 and treatment outcome in study participants at the Dafra health district medical centre, Burkina Faso 2008–2010: a artemether–lumefantrine arm, b artesunate amodiaquine arm. D0 day of inclusion before treatment administration, NI new infection, R recrudescent, ACPR adequate clinical and parasitological response, DHA dihydroartemisinin, Lum lumefantrine, MDA monodesethylamodiaquine, IC50 50% inhibitory concentrationBack to article page